201 related articles for article (PubMed ID: 22054098)
1. Salmonella-mediated tumor-targeting TRAIL gene therapy significantly suppresses melanoma growth in mouse model.
Chen J; Yang B; Cheng X; Qiao Y; Tang B; Chen G; Wei J; Liu X; Cheng W; Du P; Huang X; Jiang W; Hu Q; Hu Y; Li J; Hua ZC
Cancer Sci; 2012 Feb; 103(2):325-33. PubMed ID: 22054098
[TBL] [Abstract][Full Text] [Related]
2. Synergistic antitumoral effects of human telomerase reverse transcriptase-mediated dual-apoptosis-related gene vector delivered by orally attenuated Salmonella enterica Serovar Typhimurium in murine tumor models.
Fu W; Chu L; Han X; Liu X; Ren D
J Gene Med; 2008 Jun; 10(6):690-701. PubMed ID: 18338832
[TBL] [Abstract][Full Text] [Related]
3. Radiation-inducible human tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene therapy: a novel treatment for radioresistant uveal melanoma.
Zhou Y; Song X; Jia R; Wang H; Dai L; Xu X; Gu P; Ge S; Fan X
Pigment Cell Melanoma Res; 2010 Oct; 23(5):661-74. PubMed ID: 20546535
[TBL] [Abstract][Full Text] [Related]
4. Combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and canstatin gene suppression therapy on breast tumor xenograft growth in mice.
Wang WB; Zhou YL; Heng DF; Miao CH; Cao YL
Breast Cancer Res Treat; 2008 Jul; 110(2):283-95. PubMed ID: 17899369
[TBL] [Abstract][Full Text] [Related]
5. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
[TBL] [Abstract][Full Text] [Related]
6. Potent antitumor effect of TRAIL mediated by a novel adeno-associated viral vector targeting to telomerase activity for human hepatocellular carcinoma.
Wang Y; Huang F; Cai H; Zhong S; Liu X; Tan WS
J Gene Med; 2008 May; 10(5):518-26. PubMed ID: 18338833
[TBL] [Abstract][Full Text] [Related]
7. Proteomic screening of anaerobically regulated promoters from Salmonella and its antitumor applications.
Chen J; Wei D; Zhuang H; Qiao Y; Tang B; Zhang X; Wei J; Fang S; Chen G; Du P; Huang X; Jiang W; Hu Q; Hua ZC
Mol Cell Proteomics; 2011 Jun; 10(6):M111.009399. PubMed ID: 21474796
[TBL] [Abstract][Full Text] [Related]
8. Antitumor therapeutic effects of Salmonella typhimurium containing Flt3 Ligand expression plasmids in melanoma-bearing mouse.
Yoon WS; Choi WC; Sin JI; Park YK
Biotechnol Lett; 2007 Apr; 29(4):511-6. PubMed ID: 17235489
[TBL] [Abstract][Full Text] [Related]
9. Tumor-targeted Salmonella as a novel anticancer vector.
Pawelek JM; Low KB; Bermudes D
Cancer Res; 1997 Oct; 57(20):4537-44. PubMed ID: 9377566
[TBL] [Abstract][Full Text] [Related]
10. A capsid-modified, conditionally replicating oncolytic adenovirus vector expressing TRAIL Leads to enhanced cancer cell killing in human glioblastoma models.
Wohlfahrt ME; Beard BC; Lieber A; Kiem HP
Cancer Res; 2007 Sep; 67(18):8783-90. PubMed ID: 17875719
[TBL] [Abstract][Full Text] [Related]
11. Systemic administration of attenuated Salmonella choleraesuis carrying thrombospondin-1 gene leads to tumor-specific transgene expression, delayed tumor growth and prolonged survival in the murine melanoma model.
Lee CH; Wu CL; Shiau AL
Cancer Gene Ther; 2005 Feb; 12(2):175-84. PubMed ID: 15375381
[TBL] [Abstract][Full Text] [Related]
12. Tumour-targeted delivery of TRAIL using Salmonella typhimurium enhances breast cancer survival in mice.
Ganai S; Arenas RB; Forbes NS
Br J Cancer; 2009 Nov; 101(10):1683-91. PubMed ID: 19861961
[TBL] [Abstract][Full Text] [Related]
13. Efficient melanoma cell killing and reduced melanoma growth in mice by a selective replicating adenovirus armed with tumor necrosis factor-related apoptosis-inducing ligand.
Fecker LF; Rückert S; Kurbanov BM; Schmude M; Stockfleth E; Fechner H; Eberle J
Hum Gene Ther; 2011 Apr; 22(4):405-17. PubMed ID: 20977303
[TBL] [Abstract][Full Text] [Related]
14. AAV-mediated TRAIL gene expression driven by hTERT promoter suppressed human hepatocellular carcinoma growth in mice.
Zhang Y; Ma H; Zhang J; Liu S; Liu Y; Zheng D
Life Sci; 2008 Jun; 82(23-24):1154-61. PubMed ID: 18485417
[TBL] [Abstract][Full Text] [Related]
15. [Specific antitumor effect of adeno-associated virus vector carrying TRAIL gene under the control of hTERT promoter].
Qi R; Cai Y; Li BH; Lin ZX; Gu JF
Ai Zheng; 2008 Oct; 27(10):1026-33. PubMed ID: 18851780
[TBL] [Abstract][Full Text] [Related]
16. The antitumor activity of TRAIL and IL-24 with replicating oncolytic adenovirus in colorectal cancer.
Zhao L; Dong A; Gu J; Liu Z; Zhang Y; Zhang W; Wang Y; He L; Qian C; Qian Q; Liu X
Cancer Gene Ther; 2006 Nov; 13(11):1011-22. PubMed ID: 16799468
[TBL] [Abstract][Full Text] [Related]
17. [Anti-tumor effect of eukaryotic expressing plasmid containing soluble tumor necrotic factor-related apoptosis inducing ligand combined with human angiostatin Kringle (1 - 3) genes on human gastric cancer xenografts in nude mice].
Sun W; Jiang Z; Xiang TX; Tao XH; Huang AL; Wang PL
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(12):841-5. PubMed ID: 19595126
[TBL] [Abstract][Full Text] [Related]
18. Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
Itashiki Y; Harada K; Ferdous T; Yoshida H
Anticancer Res; 2007; 27(4B):2365-75. PubMed ID: 17695527
[TBL] [Abstract][Full Text] [Related]
19. Suppressing orthotopic pancreatic tumor growth with a fiber-modified adenovector expressing the TRAIL gene from the human telomerase reverse transcriptase promoter.
Jacob D; Davis J; Zhu H; Zhang L; Teraishi F; Wu S; Marini FC; Fang B
Clin Cancer Res; 2004 May; 10(10):3535-41. PubMed ID: 15161713
[TBL] [Abstract][Full Text] [Related]
20. Cytosine deaminase/5-fluorocytosine gene therapy and Apo2L/TRAIL cooperate to kill TRAIL-resistant tumor cells.
Wei J; Wahl J; Knauss H; Zeller S; Jarmy G; Fitze G; Debatin KM; Beltinger C
Cancer Gene Ther; 2007 Jul; 14(7):640-51. PubMed ID: 17479107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]